Search
01/06/2023
Robot-assisted vs. open radical cystectomy: Systematic review and meta-analysis of randomized controlled trials
Fontanet S., Basile G., Baboudjian M., Gallioli A., Huguet J., Territo A., Parada R., Gavrilov P., Aumatell J., Sanz I., Bravo-Balado A., Verri P., Uleri A., Gaya J.M., Palou J., Breda A.. Robot-assisted vs. open radical cystectomy: Systematic review and meta-analysis of randomized controlled trials. Actas Urologicas Espanolas. 2023; 47(5)DOI:10.1016/j.acuro.2022.11.003. PMID:36737037. IF:1.200(Q3/8D).
01/06/2023
Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review
Fontanet S., Gallioli A., Baboudjian M., Huguet J., Territo A., Gaya J.M., Gavrilov P., Izquierdo P., Verri P., Algaba F., Palou J., Breda A.. Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2023; 41(6)DOI:10.1016/j.urolonc.2022.11.001. PMID:36526527. IF:2.400(Q2/4D).
01/06/2023
New multiport robotic surgical systems: a comprehensive literature review of clinical outcomes in urology
Salkowski, M, Checcucci, E, Chow, AK, Rogers, CC, Adbollah, F, Liatsikos, E, Dasgupta, P, Guimaraes, GC, Rassweiler, J, Mottrie, A, Breda, A, Crivellaro, S, Kaouk, J, Porpiglia, F, Autorino, R. New multiport robotic surgical systems: a comprehensive literature review of clinical outcomes in urology. Therapeutic Advances in Urology. 2023; 15DOI:10.1177/17562872231177781. PMID:37325289. IF:2.600(Q2/4D).
01/06/2023
Comment on: "Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma"
Asero, V, Scornajenghi, CM, Krajewski, W, Szydelko, T, Malkiewicz, B, Nowak, L, Gallioli, A, Basran, S, Chung, BI, del Giudice, F. Comment on: "Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma". Minerva Urology And Nephrology. 2023; 75(3)DOI:10.23736/S2724-6051.23.05354-5. PMID:37221829. IF:4.900(Q1/2D).
01/06/2023
Comment on: "Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG"
Lonati, C, Soria, F, Pradere, B, D'Andrea, D, Laukhtina, E, Mertens, LS, Albisinni, S, Krajewski, W, Afferi, L, Del Giudice, F, Gallioli, A, Moschini, M, Urothelial Carcinoma Working Grp. Comment on: "Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG". Minerva Urology And Nephrology. 2023; 75(3)DOI:10.23736/S2724-6051.23.05337-5. PMID:37221831. IF:4.900(Q1/2D).
01/06/2023
Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis.
Ruiz-Villaverde R, Galán-Gutiérrez M, Llamas-Velasco M, Salgado-Boquete L, Puig L, de la Cueva P, Carrascosa JM. Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis.. Actas Dermo-Sifiliograficas. 2023; 114(6)DOI:10.1016/j.ad.2023.02.016. PMID:36906260. IF:(Q/D).